News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
12 Results
Section
Business (4)
Drug Development (6)
News (9)
Tag
Alliances (2)
Clinical research (6)
People (1)
Phase I (6)
Startups (1)
Date
2023 (1)
2020 (1)
2018 (2)
2016 (3)
2015 (5)
Location
Asia (2)
Europe (1)
12 Results for "strategia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Strategia Holdings Announces Strategic Partnership Alliance with JS InnoPharm (Shanghai) for Global Drug Development
Strategia Holdings, LLC. announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate global drug development.
August 27, 2018
·
2 min read
Business
Strategia Spins Out SOLA Biosciences To Commercialize Tapboost Technology
February 23, 2016
·
2 min read
Genetown
Strategia Therapeutics Announces New Website Launch
August 10, 2015
·
3 min read
Business
Strategia Therapeutics Forms Oncology/Hematology Medical Advisory Board
July 20, 2015
·
4 min read
Genetown
Boston Strategics Corporation Announces Name To Strategia Therapeutics, Inc.
April 9, 2015
·
1 min read
Drug Development
Strategia Therapeutics Initiates A Phase 1 Clinical Trial Of The Radioimmunotherapeutic “FF-21101" For FUJIFILM In Patients With Advanced Cancers
January 18, 2016
·
2 min read
Drug Development
Strategia Initiates A Phase I Clinical Trial Of The Anti-Cancer Agent “FF-10502" For FUJIFILM In Patients With Advanced Cancers
February 19, 2016
·
2 min read
Drug Development
Strategia Therapeutics Announces Progress In A Phase 1 Clinical Trial Of The Anti-Cancer Agent “FF-10501-01" For FUJIFILM In Patients With Advanced Hematologic Malignancies
December 28, 2015
·
2 min read
Drug Development
Strategia Therapeutics Initiates A Phase 1/2a Clinical Trial Of The Anti-Cancer Agent E6201 In Patients With Advanced Hematologic Malignancies
April 22, 2015
·
3 min read
Drug Development
JS InnoPharm Initiates Treatment With JSI-1187, a Selective ERK Inhibitor, in Combination With Dabrafenib for Advanced Solid Tumors With BRAF V600E/K mutations
JS InnoPharm Ltd initiated the JSI-1187 plus dabrafenib combination dose-escalation phase of the Phase 1 study for patients with locally advanced or metastatic solid tumors with confirmed BRAF V600E/K mutations (NCT04418167).
January 3, 2023
·
2 min read
1 of 2
Next
